Medication and Facilitation of Transgender Women’s Lactation

@article{Paynter2019MedicationAF,
  title={Medication and Facilitation of Transgender Women’s Lactation},
  author={Martha Jane Paynter},
  journal={Journal of Human Lactation},
  year={2019},
  volume={35},
  pages={239 - 243}
}
  • M. Paynter
  • Published 6 March 2019
  • Medicine
  • Journal of Human Lactation
Early in 2018, Reisman and Goldstein published a landmark case report of induced lactation in a transgender woman which received international attention by news media (The Guardian, 2018; Yenginsu, 2018). The baby breastfed exclusively for six weeks and was still breastfeeding at six months, when the article was submitted (Reisman & Goldstein, 2018). The patient was prescribed domperidone for lactation induction, spironolactone to block androgens, and estradiol and progesterone as feminizing… 
2 Citations

Knowledge and practice of induction of lactation in trans women among professionals working in trans health

This exploratory study demonstrates healthcare professionals’ interest in breastfeeding protocols for lactation induction in trans women and explores the concept of unmet need.

Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa

No abstract available.

References

SHOWING 1-10 OF 49 REFERENCES

Case Report: Induced Lactation in a Transgender Woman

A 30-year-old transgender woman who had been receiving feminizing hormone therapy for the past 6 years was able to achieve sufficient breast milk volume to be the sole source of nourishment for her child for 6 weeks, illustrating that, in some circumstances, modest but functional lactation can be induced in transgender women.

Transmasculine individuals’ experiences with lactation, chestfeeding, and gender identity: a qualitative study

The majority of participants chose to chestfeed while some did not due to physical or mental health reasons, and care providers should communicate an understanding of gender dysphoria and transgender identities in order to build patient trust and provide competent care.

Breastfeeding in Chronic Illness: The Voices of Women With Fibromyalgia

  • K. Schaefer
  • Medicine
    MCN. The American journal of maternal child nursing
  • 2004
Knowing that the pain, muscle soreness, stiffness, and fatigue of FM may affect breastfeeding can direct nurses to help women with FM plan for support after childbirth and learn techniques to control/reduce the muscle pain and stiffness.

Postpartum women’s use of medicines and breastfeeding practices: a systematic review

The objectives of this article are to systematically review i) the extent of medicine use in postpartum women, and ii) the impact of maternal medicine use (excluding contraceptives and galactogogues)

Lactation Support and the LGBTQI Community

  • A. Farrow
  • Medicine
    Journal of human lactation : official journal of International Lactation Consultant Association
  • 2015
Health research shows that LGBTQI people have limited access to health care due to factors such as poverty, homelessness, gender-specific care and services, ineligibility for health insurance coverage due to marriage discrimination laws, fear of violence, refusal of care, substandard care without consideration of noncisgender heteronormative needs, and derogatory or moralistic comments from providers.

Breastfeeding and sexual difference: Queering Irigaray

It is commonly assumed that only women, and in particular women who have recently given birth, are able to breastfeed. However, through induced lactation, adoptive mothers, fathers and trans people

Use of Domperidone as a Galactagogue Drug

  • C. PaulM. Zénut D. Balayssac
  • Medicine
    Journal of human lactation : official journal of International Lactation Consultant Association
  • 2015
The benefit-risk ratio of domperidone as a galactagogue was assessed following a literature search of the PubMed database up to July 2013 and an improvement of breastfeeding practices seems to be more effective and safer than the use of an off-label domperidine treatment.

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.

This review found that six months treatment with 100 mg/day spironolactone compared with placebo was associated with a statistically significant subjective improvement in hair growth and a decrease in Ferriman-Galwey scores 12 months after the end of treatment.

Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production.

The objective of this review is to analyze to the literature relating to the principal drugs used as galactogogues (metoclopramide, domperidone, chlorpromazine, sulpiride, oxytocin, growth hormone, thyrotrophin releasing hormone, medroxyprogesterone), and evaluate their mechanism of action, transfer to maternal milk, effectiveness and potential side effects.